314 related articles for article (PubMed ID: 30246632)
1. Delving Deeper into Dermal and Transdermal Drug Delivery: Factors and Mechanisms Associated with Nanocarrier-mediated Strategies.
Manikkath J; Sumathy TK; Manikkath A; Mutalik S
Curr Pharm Des; 2018; 24(27):3210-3222. PubMed ID: 30246632
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
3. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
Yang M; Gu Y; Tang X; Wang T; Liu J
Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles for dermal drug delivery.
Kakadia PG; Conway BR
Curr Pharm Des; 2015; 21(20):2823-9. PubMed ID: 25925115
[TBL] [Abstract][Full Text] [Related]
5. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
Zorec B; Zupančič Š; Kristl J; Pavšelj N
Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery.
Khan NR; Harun MS; Nawaz A; Harjoh N; Wong TW
Curr Pharm Des; 2015; 21(20):2848-66. PubMed ID: 25925113
[TBL] [Abstract][Full Text] [Related]
7. Navigating Skin Delivery Horizon: An Innovative Approach in Pioneering Surface Modification of Ultradeformable Vesicles.
Nayak D; Rathnanand M; Tippavajhala VK
AAPS PharmSciTech; 2024 Jun; 25(5):126. PubMed ID: 38834910
[TBL] [Abstract][Full Text] [Related]
8. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
[TBL] [Abstract][Full Text] [Related]
9. Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs).
Souto EB; Macedo AS; Dias-Ferreira J; Cano A; Zielińska A; Matos CM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575907
[TBL] [Abstract][Full Text] [Related]
10. What's new in the field of phospholipid vesicular nanocarriers for skin drug delivery.
Lai F; Caddeo C; Manca ML; Manconi M; Sinico C; Fadda AM
Int J Pharm; 2020 Jun; 583():119398. PubMed ID: 32376441
[TBL] [Abstract][Full Text] [Related]
11. Advanced Drug Delivery Systems for Transdermal Delivery of Non-Steroidal Anti-Inflammatory Drugs: A Review.
Kumar L; Verma S; Singh M; Chalotra T; Utreja P
Curr Drug Deliv; 2018; 15(8):1087-1099. PubMed ID: 29875000
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers for drug delivery into and through the skin - Do existing technologies match clinical challenges?
Vogt A; Wischke C; Neffe AT; Ma N; Alexiev U; Lendlein A
J Control Release; 2016 Nov; 242():3-15. PubMed ID: 27449743
[TBL] [Abstract][Full Text] [Related]
13. Development of novel pH-sensitive nanoparticles loaded hydrogel for transdermal drug delivery.
Qindeel M; Ahmed N; Sabir F; Khan S; Ur-Rehman A
Drug Dev Ind Pharm; 2019 Apr; 45(4):629-641. PubMed ID: 30633578
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
15. Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases.
Li B; Lu G; Liu W; Liao L; Ban J; Lu Z
Int J Nanomedicine; 2023; 18():3745-3760. PubMed ID: 37457799
[TBL] [Abstract][Full Text] [Related]
16. Rhamnolipids form drug-loaded nanoparticles for dermal drug delivery.
Müller F; Hönzke S; Luthardt WO; Wong EL; Unbehauen M; Bauer J; Haag R; Hedtrich S; Rühl E; Rademann J
Eur J Pharm Biopharm; 2017 Jul; 116():31-37. PubMed ID: 28012989
[TBL] [Abstract][Full Text] [Related]
17. Cream formulation impact on topical administration of engineered colloidal nanoparticles.
Santini B; Zanoni I; Marzi R; Cigni C; Bedoni M; Gramatica F; Palugan L; Corsi F; Granucci F; Colombo M
PLoS One; 2015; 10(5):e0126366. PubMed ID: 25962161
[TBL] [Abstract][Full Text] [Related]
18. Tocopheryl phosphate mixture (TPM) as a novel lipid-based transdermal drug delivery carrier: formulation and evaluation.
Gavin PD; El-Tamimy M; Keah HH; Boyd BJ
Drug Deliv Transl Res; 2017 Feb; 7(1):53-65. PubMed ID: 27672079
[TBL] [Abstract][Full Text] [Related]
19. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam.
Dasgupta S; Ray S; Dey S; Pal P; Mazumder B
Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909
[TBL] [Abstract][Full Text] [Related]
20. Dermal and transdermal delivery of pharmaceutically relevant macromolecules.
Münch S; Wohlrab J; Neubert RHH
Eur J Pharm Biopharm; 2017 Oct; 119():235-242. PubMed ID: 28647443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
